PFR | Accession | Description | Modifications | Length | Confidence |
---|---|---|---|---|---|
163041 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 28 | ![]() |
|
163042 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 27 | ![]() |
|
163043 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 30 | ![]() |
|
163044 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 22 | ![]() |
|
163045 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 32 | ![]() |
|
163046 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 34 | ![]() |
|
163047 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 40 | ![]() |
|
163048 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 20 | ![]() |
|
163049 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 31 | ![]() |
163050 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 5-L-glutamyl glycerylphosphorylethanolamine@301 | 46 | ![]() |
163051 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 36 | ![]() |
|
163052 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 40 | ![]() |
|
163053 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 27 | ![]() |
|
163054 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 59 | ![]() |
|
163055 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 35 | ![]() |
|
163056 | Q5VTE0 | Putative elongation factor 1-alpha-like 3 | 46 | ![]() |
|
163057 | P68104 | Elongation factor 1-alpha 1 | 36 | ![]() |
|
163058 | P68104 | Elongation factor 1-alpha 1 | 40 | ![]() |
|
163059 | P68104 | Elongation factor 1-alpha 1 | 5-L-glutamyl glycerylphosphorylethanolamine@301, Trimethylation@318 | 62 | ![]() |
163060 | P68104 | Elongation factor 1-alpha 1 | 30 | ![]() |